Kevzara - direct healthcare professional communication (DHPC)

sarilumab

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Supply Constraint of Sarilumab [Kevzara®]

Key facts

• Medicine name:
  Kevzara
• Active substance:
  sarilumab
• Therapeutic area (MeSH):
  Arthritis, Rheumatoid
• Regulatory outcome:
  Variation
• DHPC type:
  Medicine shortage
• Human ATC codes:
  L04AC14
• Dissemination date:
  09/11/2021